Leptin stimulates ischemia-induced retinal neovascularization: Possible role of vascular endothelial growth factor expressed in retinal endothelial cells

Eri Suganami, Hitoshi Takagi, Hirokazu Ohashi, Kiyoshi Suzuma, Izumi Suzuma, Hideyasu Oh, Daisuke Watanabe, Tomonari Ojima, Takayoshi Suganami, Yasushi Fujio, Kazuwa Nakao, Yoshihiro Ogawa, Nagahisa Yoshimura

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Diabetic retinopathy is the leading cause of new blindness in adults in developed countries. Leptin, an adipocyte-derived hormone, stimulates endothelial proliferation and angiogenesis. This study was designed to elucidate the pathophysiologic role of leptin in the progression of retinal neovascularization. Using the retinopathy of prematurity model, a mouse model of ischemia-induced retinal neovascularization, we have demonstrated more pronounced retinal neovascularization in 17-day-old transgenic mice overexpressing leptin than in age-matched wild-type littermates. Ischemia-induced retinal neovascularization was markedly suppressed in 17-day-old leptin-deficient ob/ob mice. Western blot analysis revealed that a biologically active leptin receptor isoform is expressed in mouse retinal endothelial cells. Leptin receptor expression was also detected in primary cultures of porcine retinal endothelial cells, where it upregulated vascular endothelial growth factor (VEGF) mRNA expression. This effect was thought to be mediated at least partly through the activation of signal transducers and activators of transcription (STAT)3, because adenoviral transfection of the dominant-negative form of STAT3 abolished the leptin-induced upregulation of VEGF mRNA expression in retinal endothelial cells. This study provides evidence that leptin stimulates the ischemia-induced retinal neovasucularization possibly through the upregulation of endothelial VEGF, thereby suggesting that leptin antagonism may offer a novel therapeutic strategy to prevent or treat diabetic retinopathy.

Original languageEnglish
Pages (from-to)2443-2448
Number of pages6
JournalDiabetes
Volume53
Issue number9
DOIs
Publication statusPublished - Sep 1 2004

Fingerprint

Retinal Neovascularization
Leptin
Vascular Endothelial Growth Factor A
Ischemia
Endothelial Cells
Leptin Receptors
Diabetic Retinopathy
Up-Regulation
STAT3 Transcription Factor
Retinopathy of Prematurity
Messenger RNA
Blindness
Developed Countries
Adipocytes
Transgenic Mice
Transfection
Protein Isoforms
Swine
Western Blotting
Hormones

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Leptin stimulates ischemia-induced retinal neovascularization : Possible role of vascular endothelial growth factor expressed in retinal endothelial cells. / Suganami, Eri; Takagi, Hitoshi; Ohashi, Hirokazu; Suzuma, Kiyoshi; Suzuma, Izumi; Oh, Hideyasu; Watanabe, Daisuke; Ojima, Tomonari; Suganami, Takayoshi; Fujio, Yasushi; Nakao, Kazuwa; Ogawa, Yoshihiro; Yoshimura, Nagahisa.

In: Diabetes, Vol. 53, No. 9, 01.09.2004, p. 2443-2448.

Research output: Contribution to journalArticle

Suganami, E, Takagi, H, Ohashi, H, Suzuma, K, Suzuma, I, Oh, H, Watanabe, D, Ojima, T, Suganami, T, Fujio, Y, Nakao, K, Ogawa, Y & Yoshimura, N 2004, 'Leptin stimulates ischemia-induced retinal neovascularization: Possible role of vascular endothelial growth factor expressed in retinal endothelial cells', Diabetes, vol. 53, no. 9, pp. 2443-2448. https://doi.org/10.2337/diabetes.53.9.2443
Suganami, Eri ; Takagi, Hitoshi ; Ohashi, Hirokazu ; Suzuma, Kiyoshi ; Suzuma, Izumi ; Oh, Hideyasu ; Watanabe, Daisuke ; Ojima, Tomonari ; Suganami, Takayoshi ; Fujio, Yasushi ; Nakao, Kazuwa ; Ogawa, Yoshihiro ; Yoshimura, Nagahisa. / Leptin stimulates ischemia-induced retinal neovascularization : Possible role of vascular endothelial growth factor expressed in retinal endothelial cells. In: Diabetes. 2004 ; Vol. 53, No. 9. pp. 2443-2448.
@article{245ca5fe949c42cebbe0b9e63b8509b9,
title = "Leptin stimulates ischemia-induced retinal neovascularization: Possible role of vascular endothelial growth factor expressed in retinal endothelial cells",
abstract = "Diabetic retinopathy is the leading cause of new blindness in adults in developed countries. Leptin, an adipocyte-derived hormone, stimulates endothelial proliferation and angiogenesis. This study was designed to elucidate the pathophysiologic role of leptin in the progression of retinal neovascularization. Using the retinopathy of prematurity model, a mouse model of ischemia-induced retinal neovascularization, we have demonstrated more pronounced retinal neovascularization in 17-day-old transgenic mice overexpressing leptin than in age-matched wild-type littermates. Ischemia-induced retinal neovascularization was markedly suppressed in 17-day-old leptin-deficient ob/ob mice. Western blot analysis revealed that a biologically active leptin receptor isoform is expressed in mouse retinal endothelial cells. Leptin receptor expression was also detected in primary cultures of porcine retinal endothelial cells, where it upregulated vascular endothelial growth factor (VEGF) mRNA expression. This effect was thought to be mediated at least partly through the activation of signal transducers and activators of transcription (STAT)3, because adenoviral transfection of the dominant-negative form of STAT3 abolished the leptin-induced upregulation of VEGF mRNA expression in retinal endothelial cells. This study provides evidence that leptin stimulates the ischemia-induced retinal neovasucularization possibly through the upregulation of endothelial VEGF, thereby suggesting that leptin antagonism may offer a novel therapeutic strategy to prevent or treat diabetic retinopathy.",
author = "Eri Suganami and Hitoshi Takagi and Hirokazu Ohashi and Kiyoshi Suzuma and Izumi Suzuma and Hideyasu Oh and Daisuke Watanabe and Tomonari Ojima and Takayoshi Suganami and Yasushi Fujio and Kazuwa Nakao and Yoshihiro Ogawa and Nagahisa Yoshimura",
year = "2004",
month = "9",
day = "1",
doi = "10.2337/diabetes.53.9.2443",
language = "English",
volume = "53",
pages = "2443--2448",
journal = "Diabetes",
issn = "0012-1797",
publisher = "医学出版",
number = "9",

}

TY - JOUR

T1 - Leptin stimulates ischemia-induced retinal neovascularization

T2 - Possible role of vascular endothelial growth factor expressed in retinal endothelial cells

AU - Suganami, Eri

AU - Takagi, Hitoshi

AU - Ohashi, Hirokazu

AU - Suzuma, Kiyoshi

AU - Suzuma, Izumi

AU - Oh, Hideyasu

AU - Watanabe, Daisuke

AU - Ojima, Tomonari

AU - Suganami, Takayoshi

AU - Fujio, Yasushi

AU - Nakao, Kazuwa

AU - Ogawa, Yoshihiro

AU - Yoshimura, Nagahisa

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Diabetic retinopathy is the leading cause of new blindness in adults in developed countries. Leptin, an adipocyte-derived hormone, stimulates endothelial proliferation and angiogenesis. This study was designed to elucidate the pathophysiologic role of leptin in the progression of retinal neovascularization. Using the retinopathy of prematurity model, a mouse model of ischemia-induced retinal neovascularization, we have demonstrated more pronounced retinal neovascularization in 17-day-old transgenic mice overexpressing leptin than in age-matched wild-type littermates. Ischemia-induced retinal neovascularization was markedly suppressed in 17-day-old leptin-deficient ob/ob mice. Western blot analysis revealed that a biologically active leptin receptor isoform is expressed in mouse retinal endothelial cells. Leptin receptor expression was also detected in primary cultures of porcine retinal endothelial cells, where it upregulated vascular endothelial growth factor (VEGF) mRNA expression. This effect was thought to be mediated at least partly through the activation of signal transducers and activators of transcription (STAT)3, because adenoviral transfection of the dominant-negative form of STAT3 abolished the leptin-induced upregulation of VEGF mRNA expression in retinal endothelial cells. This study provides evidence that leptin stimulates the ischemia-induced retinal neovasucularization possibly through the upregulation of endothelial VEGF, thereby suggesting that leptin antagonism may offer a novel therapeutic strategy to prevent or treat diabetic retinopathy.

AB - Diabetic retinopathy is the leading cause of new blindness in adults in developed countries. Leptin, an adipocyte-derived hormone, stimulates endothelial proliferation and angiogenesis. This study was designed to elucidate the pathophysiologic role of leptin in the progression of retinal neovascularization. Using the retinopathy of prematurity model, a mouse model of ischemia-induced retinal neovascularization, we have demonstrated more pronounced retinal neovascularization in 17-day-old transgenic mice overexpressing leptin than in age-matched wild-type littermates. Ischemia-induced retinal neovascularization was markedly suppressed in 17-day-old leptin-deficient ob/ob mice. Western blot analysis revealed that a biologically active leptin receptor isoform is expressed in mouse retinal endothelial cells. Leptin receptor expression was also detected in primary cultures of porcine retinal endothelial cells, where it upregulated vascular endothelial growth factor (VEGF) mRNA expression. This effect was thought to be mediated at least partly through the activation of signal transducers and activators of transcription (STAT)3, because adenoviral transfection of the dominant-negative form of STAT3 abolished the leptin-induced upregulation of VEGF mRNA expression in retinal endothelial cells. This study provides evidence that leptin stimulates the ischemia-induced retinal neovasucularization possibly through the upregulation of endothelial VEGF, thereby suggesting that leptin antagonism may offer a novel therapeutic strategy to prevent or treat diabetic retinopathy.

UR - http://www.scopus.com/inward/record.url?scp=4344619563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344619563&partnerID=8YFLogxK

U2 - 10.2337/diabetes.53.9.2443

DO - 10.2337/diabetes.53.9.2443

M3 - Article

C2 - 15331557

AN - SCOPUS:4344619563

VL - 53

SP - 2443

EP - 2448

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -